Sarfaraz Niazi | PROFESSOR
University of Illinois

Professor Niazi is a pioneer of biosimilars, having created the term with extensive experience of advising the FDA, EMA, MHRA, the US Senate, and the White House on legislation related to biosimilars; he has been able to bring many changes that now make biosimilars affordable. He established the first biosimilar company in the US and secured approval of several products. He is now steering the mRNA technology as an alternate to recombinant expression of peptides, proteins, mAbs, and vaccines; he has published over 150 research papers, owns over 250 US patents, and has numerous civic and scientific recognitions. He serves as the editor of major journals and advises companies and agencies on a pro bono basis worldwide to make biologicals affordable. He can be reached at niazi@niazi.com